Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram plus benznidazole for chronic Chagas disease
RBR-5n4htpPhase 2Recruiting
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of disulfiram and benznidazole in American trypanosomiasis (CD) (6 arms), sponsored by Fundação Oswaldo Cruz. Started Jan 2020; status: recruiting.
02
Drugs
disulfirambenznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on RBR-5n4htp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5n4htp.